Activ8rlives Adds SmartOne Peak Flow and FEV1 Wireless Meter to its Health Monitoring Solution for Pulmonary Disease Sufferers
Posted on June 6, 2016
The Activ8rlives SmartOne® Peak Flow and FEV1 Meter extends our range of Bluetooth Smart devices, allowing individuals to monitor their lung function from home and send their data via the Activ8rlives4 Health+Wellness App (iOS and Android) to the new Activ8rlives 3.0 online healthcare solution, compliant with the NHS Information Governance ToolKit as a Self-Care tool for patient-generated data.
The SmartOne® Peak Flow and FEV1 Meter helps patients to understand how their lung function changes throughout the week, during periods of ill health, change of medication or as they change weight and activity levels. It measures Peak Expiratory Flow rate (PEF) and Forced Expiratory Flow at 1 second (FEV1) using a non-invasive simple-to-use wireless monitoring technology. The use of a Peak Flow meter is especially useful if patients have Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF) or Bronchiectasis (NCFB).
Peak flow values are often classified into three coloured zones using the traffic light system of measurement according to the American Lung Association: Green, Yellow and Red. The SmartOne and Activ8rlives App automatically stores the highest (best) value and prompts individuals to blow three times as hard and as fast to move the silver balls up the measuring cylinders for their best reading. Within the Activ8rlives account, respiratory patients can set their own ‘normal’ targets or those calculated automatically by the system using the NHANES III population scales.
Aseptika’s Asthma+me solution announced as Winner of Best Patient-Focused Technological Development in 2019 Clinical & Research Excellence Awards
Posted on May 7, 2019
Self-care: Councils helping people look after themselves
Posted on March 11, 2019
Asthma: Young people in the UK 'more likely to die'
Posted on February 20, 2019
Young people are at higher risk of having an asthma attack than any other age group living with the condition, the charity Asthma UK is warning
Posted on January 23, 2019
Aseptika wins grant from Innovate UK to undertake a clinical trial with its child asthma solution
Posted on January 21, 2019